The most common cause of re-revision of the hip after revision surgery is failure of the acetabular component (Swedish Hip Arthrolasty Register [@CIT0026]). Acetabular revision with cemented implants has shown up to 20% failure at 10 years of follow-up, whereas contemporary designs of uncemented acetabular cups have substantially reduced this failure rate ([@CIT0001], [@CIT0010], [@CIT0009], [@CIT0012]). Loosening of the primary acetabular component often leaves substantial bone loss and a sclerotic acetabular bed. Fixation of revision cups is therefore demanding, and several techniques have been used to restore bone loss and achieve long-term fixation of the revision cup---such as screw fixation, bone grafting, and different cup designs ([@CIT0018], [@CIT0021]). The use of hydroxyapatite (HA) coating on cups used as revision implants has been proposed to be an improvement over uncoated cups ([@CIT0004], [@CIT0005]).

HA is the main inorganic component of human bone. It has therefore been hypothesized that coating of metallic implants with HA enhances ingrowth of bone and thus leads to improved stability ([@CIT0027]). Indeed, some HA-coated cups perform well and are still in use, while other HA-coated cups have shown high failure rates in the long term. For instance, inferior results were achieved with the Romanus cup where the combination of an inferior locking mechanism of the liner with an inferior type of polyethylene resulted in excessive osteolysis in the acetabular region ([@CIT0022], [@CIT0013], [@CIT0011], [@CIT0026]). Due to the relatively small numbers of revision procedures, very few authors have reported results after hip revision arthroplasty using HA-coated implants. To our knowledge, there have been no registry studies specifically investigating the performance of HA-coated hip revision implants. Thus, the question of whether the use of HA coating on revision cups is beneficial remains to be answered.

In this study, we analyzed the outcome of acetabular revision surgery using uncemented cups with or without HA coating recorded in the Swedish Hip Arthroplasty Register (SHAR). Our hypothesis was that coating of revision acetabular cups with HA reduces the risk of re-revision of the acetabular component inserted. The primary endpoint was re-revision of the acetabular component for any reason and the secondary endpoint was re-revision of the cup due to aseptic loosening.

Patients and methods {#ss1}
====================

Source of data {#ss2}
--------------

Our data were derived from the SHAR ([@CIT0026]). Primary and revision hip arthroplasties performed in Sweden, both in public and private orthopedic units, have been reported to the Register since 1979. From 1992, data from primary procedures were linked to the personal ID number of each patient, providing information relevant to follow-up---such as changes of address, dates of emigration, or death. In this study we used the reoperation database, which includes personal ID numbers from the start of the Register in 1979. Information on the type of implant and fixation, and technical details, are recorded from the case records of each reoperation and entered into the database. In this database, reoperations are also recorded when the patient undergoes more than one operation of the same hip. For this study, only primary revisions using uncemented cups available with and without HA coating and any subsequent revision of these cups (irrespective of implant used at re-revision) were analyzed (index operation). The term "cup revision" was defined as an intervention where 1 or more components of the cup (shell, liner, or both) were removed. Thus, other types of reoperations where the implant was left untouched---or where only the stem was exchanged---were disregarded in this study. The SHAR has been repeatedly validated, and the completeness has been described to be about 99% for primary hip arthroplasties and 94% for revision hip arthroplasties ([@CIT0028], [@CIT0029], [@CIT0026]), although one study indicated a lower degree of completeness ([@CIT0017]).

Study population and characteristics {#ss3}
------------------------------------

We identified uncemented cups, with or without HA coating, that were registered in the SHAR reoperation database between 1979 and 2009 and used as components for the first acetabular revision performed after primary hip arthroplasty (1,780 hips in 1,772 patients). There were 2 such cup designs: Harris-Galante I and II (Zimmer Inc., Warsaw, IN; n = 340) and Trilogy (Zimmer Inc.; n = 1,440). They had been used in revision procedures between 1986 and 2009. The Harris-Galante I was introduced to the Swedish market in 1984. 4 years later, the Harris-Galante II with a thicker acetabular shell and wider screws became available. This design was gradually replaced by the Trilogy cup, with an improved locking mechanism in 1993.

All the cups investigated were hemispherical press-fit shells made of titanium alloy with a porous coating consisting of commercially pure titanium, and all were available either with or without HA coating. Thus, 4 different implants were available for analysis: HA-coated Harris-Galante, uncoated Harris-Galante, HA-coated Trilogy, and uncoated Trilogy. The ceramic coating on the Harris-Galante and Trilogy cups consists of a mixture of HA (70%) and tricalcium phosphate (30%) with a thickness of 70 µm and 50% crystallinity. The cups were combined with different types of liners that were all made of conventional polyethylene until 1999, when highly crosslinked polyethylene (XLPE) was introduced and gradually replaced the older type of polyethylene over a period of 8--9 years.

1,772 patients received uncemented acetabular revision cups of the uncemented designs mentioned above. 8 patients had revisions in both hips, resulting in a total of 1,780 hips for analysis.

Statistics {#ss4}
----------

Follow-up started on the day of revision THA and ended on the day of re-revision, death, emigration, or December 31, 2009 (whichever came first). Unadjusted survival with revision for any reason or due to aseptic loosening was calculated according to Kaplan-Meier. A Cox proportional hazards model was used in order to analyze the relative risk (RR) of re-revision of the cup component inserted at the first revision---either for any reason or due to aseptic loosening. The absence or presence of HA coating, age at index cup revision (\< 50, 50--59, 60--75, \> 75 years), sex, cause of index cup revision (aseptic loosening, dislocation, infection, or other cause(s)), cup design (Harris-Galante or Trilogy), the use of bone graft at index cup revision, and the type of cup fixation in primary THA (cemented or uncemented) were considered relevant covariates. Other covariates were investigated in an exploratory manner: the type of hospital where the primary or the revision surgery was performed, age at primary THA, diagnosis underlying primary THA, and type of stem fixation in revision arthroplasty when a total revision (including stem revision) was performed. An initial analysis investigated the covariates mentioned above as singular variables, and a crude RR was calculated for each variable. Then the covariates mentioned above were entered in the regression model and mutually adjusted for other covariates. The assumption of proportional hazards was investigated by hazard function plots and log-minus-log plots of all covariates. There was no sign of insufficient proportionality in the hazard functions, and log-minus-log plots ran parallel for all covariates.

Re-revision of the cup was defined as exchange of the liner or exchange or removal of the liner together with the metal shell. In another set of analyses, we separately investigated procedures where either only the liner or both liner and metal shell had been exchanged or extracted, either for any reason or due to aseptic loosening.

8 patients had undergone bilateral revisions with use of either of the 4 cup designs selected for this study. In order to investigate dependency issues ([@CIT0023]), we performed a separate analysis excluding the cup revision in the second hip in these patients but found that parameter estimates were not affected when 1,780 or only 1,772 hips were included.

Categorical data were investigated using the chi-square test. Statistical analyses were performed using SPSS software (version 19.0). The R software package (version 2.14.1) was used in order to plot survival functions according to Kaplan-Meier, and p-values less than 0.05 were considered significant.

Results {#ss5}
=======

Characteristics of the study population {#ss6}
---------------------------------------

The group with HA-coated cups was 2.5 times larger than the group with uncoated cups. Primary osteoarthritis was the most common preoperative diagnosis for primary THA ([Table 1](#T1){ref-type="table"}). Sex distribution was similar between the groups with HA-coated cups and uncoated cups. The largest number of revisions was found in patients aged between 50 and 75 years. The main cause for the index cup revision was aseptic loosening (87%). 803 (45%) of the index revisions were isolated cup revisions, and in 977 (55%) the stem was revised together with the investigated cup. The diagnosis of previous pediatric hip disease at primary hip arthroplasty was more common in the group of patients with uncoated revision cups (p = 0.03). There was a larger proportion of older patients (aged \> 75 years) in the group with HA-coated cups (p \< 0.001) and there was a larger proportion of patients with dislocation as the cause of index cup revision in the group with HA-coated cups (p = 0.03) ([Table 2](#T2){ref-type="table"}). The use of bone grafts during the index cup revision was comparable for HA-coated cups and uncoated cups (p = 0.6) ([Table 3](#T3){ref-type="table"}).

###### 

Type of diagnosis at primary THA within the 2 groups of patients with HA-coated and uncoated revision cups

  Primary diagnosis **[^b^](#T1-N2){ref-type="fn"}**   Revision cups   p-value **[^a^](#T1-N1){ref-type="fn"}**               
  ---------------------------------------------------- --------------- ------------------------------------------ ----- ----- --
  Primary OA                                           949             75                                         360   71    
  Inflammatory disease                                 99              8                                          38    8     
  Pediatric hip disease                                82              7                                          59    12    
  Fracture                                             81              6                                          25    5     
  Other diagnoses **[^c^](#T1-N3){ref-type="fn"}**     47              5                                          26    5     
  Total                                                1,258           100                                        508   100   

**^a^** Chi-square test.

**^b^** Missing data in 14 cases.

**^c^** Including secondary posttraumatic OA, idiopathic femoral head necrosis, tumor, and other type of secondary OA.

###### 

Characteristics of the study population

                                            \+ HA   -- HA   p-value **[^a^](#T2-N1){ref-type="fn"}**        
  ----------------------------------------- ------- ------- ------------------------------------------ ---- ----------
  Sex                                                                                                       0.7
    Male                                    593     47      244                                        48   
    Female                                  677     53      266                                        52   
  Age                                                                                                       \< 0.001
    \< 50                                   53      4       65                                         13   
    50--59                                  125     10      93                                         18   
    60--75                                  576     45      270                                        53   
    \> 75                                   516     41      82                                         16   
  Cause of index revision                                                                                   0.03
    Aseptic loosening                       1,084   85      456                                        89   
    Infection                               13      1       4                                          1    
    Dislocation                             84      7       16                                         3    
   Other **[^b^](#T2-N2){ref-type="fn"}**   89      7       34                                         7    

**^a^** Chi-square test.

**^b^** Including fracture, technical reasons, pain only, implant fracture.

###### 

Use of bone graft at index cup revision within the 2 groups (HA-coated and uncoated revision cups)

                                                                   \+ HA   − HA               
  ---------------------------------------------------------------- ------- ------ ----- ----- -----
  Bone graft at index operation **[^b^](#T3-N2){ref-type="fn"}**                              0.6
    Yes                                                            599     49     238   48    
    No                                                             625     51     261   52    
  Total                                                            1,224   100    499   100   

**^a^** Chi-square test.

**^b^** Missing data in 57 cases.

Re-revisions of cups {#ss7}
--------------------

Mean follow-up for all cases was 6.9 (0--24) years. The mean observation time was 4.6 years for the HA-coated cups and 10.3 years for the uncoated cups. 103 patients died during the period studied, excluding patients who died after the cup had been re-revised. By 2009, 159 (9%) of all 1,780 cups had been re-revised, mostly due to aseptic loosening (5%), dislocation (2%), or deep infection (1%). In 80 hips, only the liner had been exchanged and in 79 both the liner and the shell had been exchanged or extracted. 87 (55%) of these re-revision procedures were isolated cup re-revisions, and 72 (45%) were total hip re-revisions where the stem was also revised.

Risk of cup re-revision for any reason {#ss8}
--------------------------------------

The crude RR of HA coating for the risk of cup re-revision for any reason was 1.0 (95% CI: 0.7--1.4) ([Table 4](#T4){ref-type="table"} and [Figure 1](#F1){ref-type="fig"}). After adjustment for all other covariates, HA coating still did not have any influence on the risk of cup re-revision for any reason, with an adjusted RR of 1.4 (CI: 0.9--2.0) ([Table 4](#T4){ref-type="table"}). Age below 60 years at the time of index cup revision, dislocation as the cause of index cup revision, and the use of the Harris-Galante cup statistically significantly increased the risk of cup re-revision for any reason ([Table 4](#T4){ref-type="table"}). In separate analyses where the endpoints were either isolated re-revisions of the liner or re-revisions of both liner and metal shell, we investigated whether HA coating had any influence on the risk of re-revision of these components. We found that HA coating was a risk factor for isolated liner re-revision, with an adjusted RR of 1.8 (CI: 1.01--3.3), but HA coating had no influence on the risk of cup re-revision when isolated liner revisions were excluded (adjusted RR = 1.0, CI: 0.6--1.7).

###### 

Relative risk (RR) for cup re-revision for any reason

  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Endpoint: any reason                                            No. of hips   No. of\        Crude RR\                                    Adjusted RR\      p-value
                                                                                re-revisions   (95% CI)                                     (95% CI)          
  --------------------------------------------------------------- ------------- -------------- -------------------------------------------- ----------------- ----------
  Coating                                                                                                                                                     

    -- HA                                                         510           80             1.0 (ref) **[^a^](#T4-N1){ref-type="fn"}**   1.0 (ref)         

    + HA                                                          1,270         79             1.0 (0.7--1.4)                               1.4 (0.9--2.0)    0.1

  Age at index revision                                                                                                                                       

    0--49                                                         118           31             2.6 (1.4--5.0)                               3.5 (2.0--6.2)    0.003

    50--59                                                        218           34             2.4 (1.4--4.1)                               1.9 (1.0--3.5)    0.04

    60--75                                                        846           73             1.5 (0.9--2.5)                               1.3 (0.8--2.2)    0.3

    \> 75                                                         598           21             1.0 (ref)                                    1.0 (ref)         

  Sex                                                                                                                                                         

    Male                                                          837           68             1.0 (ref)                                    1.0 (ref)         

    Female                                                        943           91             1.1 (0.8--1.6)                               0.9 (0.7--1.3)    0.6

  Cause for index revision                                                                                                                                    

    Aseptic loosening                                             1,540         129            1.0 (ref)                                    1.0 (ref)         

    Infection                                                     17            1              1.5 (0.2--10.7)                              1.7 (0.2--12.5)   0.6

    Dislocation                                                   100           18             4.4 (2.6--7.2)                               3.8 (2.2--6.6)    \< 0.001

    Other                                                         123           11             1.3 (0.7--2.4)                               1.3 (0.7--2.5)    0.4

  Cup fixation at primary\                                                                                                                                    
  arthroplasty **[^b^](#T4-N2){ref-type="fn"}**                                                                                                               

    Cemented                                                      1,424         106            1.0 (ref)                                    1.0 (ref)         

    Uncemented                                                    339           53             1.9 (1.3--2.6)                               1.4 (0.97--2.1)   0.07

  Cup design                                                                                                                                                  

    Trilogy                                                       1,440         76             1.0 (ref)                                    1.0 (ref)         

    Harris-Galante                                                340           83             1.6 (1.1--2.3)                               1.6 (1.0--2.5)    0.03

  Bone graft at index revision **[^c^](#T4-N3){ref-type="fn"}**                                                                                               

    No use of bone graft                                          886           74             1.0 (ref)                                    1.0 (ref)         

    Use of bone graft                                             837           78             0.9 (0.6--1.2)                               0.9 (0.7--1.3)    0.7
  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------

**^a^** ref: reference group.

**^b^** Missing data in 17 cases.

**^c^** Missing data in 57 cases.

A Cox regression analysis was performed where covariates (HA coating, age at index revision, sex, cause of index cup revision, cup design, use of bone grafting at index cup revision, and cup fixation at primary arthroplasty) were initially entered as singular variables, and a crude risk ratio (RR) was calculated for each variable. Then all covariates mentioned above were entered in the regression model and risk ratios were mutually adjusted for all covariates. Crude and adjusted RRs were calculated for revision for any reason.

![Unadjusted Kaplan-Meier survival with hydroxyapatite (HA) coating as the independent factor and cup re-revision due to any reason as the endpoint. 10-year survival was 88.7% (CI: 85.5--92.0) for the HA-coated cups (red) and 87.2% (CI: 83.8--90.7) for the uncoated cups (blue). The dashed lines represent 95% confidence intervals for the 2 groups of cups.](ORT-1745-3674-083-427_g001){#F1}

Risk of cup re-revision due to aseptic loosening {#ss9}
------------------------------------------------

The crude RR of HA coating for the risk of cup re-revision due to aseptic loosening was 0.7 (CI: 0.4--1.1) ([Table 5](#T5){ref-type="table"} and [Figure 2](#F2){ref-type="fig"}) without adjustment for covariates. After adjustment for the covariates mentioned previously, we found that HA coating had no influence on the risk of cup re-revision due to aseptic loosening (adjusted RR = 1.1, CI: 0.6--1.9) ([Table 5](#T5){ref-type="table"}). The covariates age below 60 years at index cup revision, the use of a Harris-Galante cup, and the use of uncemented cup in primary arthroplasty were associated with an increased risk of cup re-revision due to aseptic loosening ([Table 5](#T5){ref-type="table"}). The analysis of the subgroup of re-revisions of metal shell and liner, excluding isolated liner re-revisions, indicated that HA coating had no influence on the risk of re-revision due to aseptic loosening: The presence of HA coating was associated with an adjusted RR of 1.0 (CI: 0.5--2.2) for re-revision of the metal shell. The use of bone graft at the index procedure did not influence the risk of cup re-revision (including liner exchanges) due to aseptic loosening (adjusted RR = 1.1, CI: 0.5--2.1) but when isolated liner revisions were excluded, bone grafting was found to be a risk factor for re-revision of the metal shell due to aseptic loosening (adjusted RR = 2.1, CI: 1.05--4.2).

###### 

Relative risk (RR) for cup re-revision due to aseptic loosening

  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Endpoint: aseptic loosening                                            No. of hips   No. of re-revisions   Crude RR\                                    Adjusted RR\      p-value
                                                                                                             (95% CI)                                     (95% CI)          
  ---------------------------------------------------------------------- ------------- --------------------- -------------------------------------------- ----------------- ---------
  Coating                                                                                                                                                                   

    -- HA                                                                510           55                    1.0 (ref) **[^a^](#T5-N1){ref-type="fn"}**   1.0 (ref)         

    + HA                                                                 1,270         26                    0.7 (0.4--1.1)                               1.1 (0.6--1.9)    0.9

  Age at index revision                                                                                                                                                     

    0--49                                                                118           21                    8.6 (2.9--25.3)                              4.3 (1.4--13.3)   0.01

    50--59                                                               218           23                    5.8 (2.0--17.0)                              3.1 (1.0--9.4)    0.05

    60--75                                                               846           33                    2.6 (0.9--7.3)                               1.9 (0.7--5.5)    0.2

    \>75                                                                 598           4                     1.0 (ref)                                    1.0 (ref)         

  Sex                                                                                                                                                                       

    Male                                                                 837           31                    1.0 (ref)                                    1.0 (ref)         

    Female                                                               943           50                    1.4 (0.9--2.1)                               1.1 (0.7--1.7)    0.8

  Cause for index revision                                                                                                                                                  

    Aseptic loosening                                                    1,540         75                    1.0 (ref)                                    1.0 (ref)         

    Infection                                                            17            0                     0.0 (0.0--∞)                                 0.0 (0.0--∞)      1.0

    Dislocation                                                          100           1                     0.6 (0.1--4.3)                               0.6 (0.1--4.6)    0.6

    Other                                                                123           5                     1.1 (0.4--2.6)                               1.4 (0.6--3.6)    0.5

  Cup fixation at primary arthroplasty**[^b^](#T5-N2){ref-type="fn"}**                                                                                                      

    Cemented                                                             1,424         45                    1.0 (ref)                                    1.0 (ref)         

    Uncemented                                                           339           36                    2.9 (1.9--4.6)                               2.2 (1.4--3.6)    0.02

  Cup design                                                                                                                                                                

    Trilogy                                                              1,440         19                    1.0 (ref)                                    1.0 (ref)         

    Harris-Galante                                                       340           62                    3.3 (1.9--5.9)                               2.7 (1.4--5.2)    0.02

  Bone graft at index revision **[^c^](#T5-N3){ref-type="fn"}**                                                                                                             

    No use of bone graft                                                 886           25                    1.0 (ref)                                    1.0 (ref)         

    Use of bone graft                                                    837           52                    1.6 (1.0--2.6)                               1.5 (0.9--2.5)    0.09
  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

**^a^** ref: reference group.

**^b^** Missing data in 17 cases.

**^c^** Missing data in 57 cases.

Cox regression analysis: See Table 4.

![Unadjusted Kaplan-Meier survival with hydroxyapatite (HA) coating as the independent factor and cup re-revision due to aseptic loosening as the endpoint. 10-year survival was 94.7% (CI: 91.9--97.5) for the HA-coated cups (red) and 91.9% (CI: 89.1--94.8) for the uncoated cups (blue). The dashed lines represent 95% confidence intervals for the 2 groups of cups.](ORT-1745-3674-083-427_g002){#F2}

Exploratory analyses {#ss10}
--------------------

Further exploratory analyses involving insertion of putatively relevant covariates into the Cox regression model were performed: (1) type of hospital where the primary surgery or the revision surgery was performed; (2) age at primary THA; (3) the diagnosis underlying primary arthroplasty; and (4) the type of stem fixation when the index cup revision was combined with a stem revision. None of the other factors mentioned above statistically significantly influenced the risk of cup re-revision---either for any reason or due to aseptic loosening---with the following exception. Insertion of the primary THA at a local hospital was a risk factor for cup re-revision for any reason ([Table 6](#T6){ref-type="table"}).

###### 

Exploratory analyses using putatively relevant covariates. Adjusted relative risk (RR) for cup re-revision for any reason

  --------------------------------------------------------------------------------------------------
  Endpoint: any reason                       Adjusted RR\                                  p-value
                                             (95% CI)                                      
  ------------------------------------------ --------------------------------------------- ---------
  Type of hospital at primary arthroplasty                                                 

   University hospital                       1.0 (ref) **[^a^](#T6-N1){ref-type="fn"}**    

   Regional hospital                         1.2 (0.8--1.8)                                0.3

   Local hospital                            1.9 (1.1--3.1)                                0.02

   Private hospital                          1.3 (0.5--3.2)                                0.6

   Hospital abroad                           1.4 (0.2--10.6)                               0.7

  Type of hospital at index cup revision                                                   

   University hospital                       1.0 (ref) **[^a^](#T6-N1){ref-type="fn"}**    

   Regional hospital                         1.2 (0.9--1.8)                                0.3

   Local hospital                            2.1 (0.9--4.9)                                0.09

   Private hospital                          1.5 (0.2--11.4)                               0.7

  Age at primary arthroplasty                                                              

   0--49                                     1.0 (ref) **[^a^](#T6-N1){ref-type="fn"}**    

   50--59                                    1.6 (0.9--3.1)                                0.2

   60--75                                    2.0 (0.9--4.4)                                0.09

   \>75                                      3.6 (0.9--13.5)                               0.06

  Diagnosis at primary arthroplasty                                                        

   OA                                        1.0 (ref) **[^a^](#T6-N1){ref-type="fn"}**    

   Other diagnosis                           1.4 (0.98--2.1)                               0.07

  Stem fixation at index revision                                                          

   Cemented                                  1.0 (ref) a**[^a^](#T6-N1){ref-type="fn"}**   

   Uncemented                                0.6 (0.3--1.2)                                0.2
  --------------------------------------------------------------------------------------------------

**^a^** ref: reference group.

For each covariate, the adjusted RR with the endpoint cup re-revision for any reason was calculated. Each covariate was entered in the Cox regression model and the risk ratio was adjusted for the covariates: sex, HA coating, age at index revision, cause of index cup revision, cup design, use of bone grafting at index cup revision, and cup fixation at primary arthroplasty.

The scenario of an unstable stem that was not revised together with the cup at the index revision procedure because it was wrongly thought to be stable could distort our results. We therefore determined whether the stem had been revised together with the cup during the index cup revision: The Cox regression model with the endpoint re-revision for any reason was applied to cases where only the cup had been revised during the index procedure (isolated cup revisions). The results of this analysis were similar to those found for the entire study population, i.e. inclusion of those cases where the stem had also been revised during the index revision procedure (total hip revisions; data not shown).

Patients who were less than 60 years of age at the time of the index cup revision had a greater risk of cup re-revision for any reason and due to aseptic loosening. A separate analysis only including patients younger than 60 years at the index cup revision revealed that HA coating did not affect the performance of the cups investigated, even in this subgroup of patients. However, the occurrence of "other diagnosis" (including fracture, technical reasons, pain only, or implant fracture) as the cause of the index cup revision and the use of an uncemented cup in primary arthroplasty were associated with an increased risk of cup re-revision for any reason and due to aseptic loosening in the group of younger patients (data not shown). In these patients, we also found that the use of bone grafting at the index revision was associated with a higher risk of cup re-revision due to aseptic loosening (data not shown).

Discussion {#ss11}
==========

HA-coated implants are widely used in both primary and revision total hip arthroplasty. In primary hip arthroplasty, the use of HA on cups appears to be questionable. Some reports have indicated that the outcome is not affected by the presence of HA coating, whereas others have shown an increased risk of cup revision after the use of HA coating ([@CIT0007], [@CIT0024], [@CIT0002], [@CIT0030], [@CIT0011]). There is very little literature on revision hip arthroplasty, and it involves very few patients, but some studies investigating the outcome of acetabular revision using uncemented HA-coated components have shown promising results ([@CIT0016], [@CIT0004], [@CIT0005], [@CIT0018]). However, to our knowledge there have been no studies comparing identical cups with or without HA coating used in revision arthroplasty. Taken together, our results show no evidence that HA coating of acetabular components used in revision THA improved the performance of the 2 cup designs under investigation.

Risk factors for cup re-revision {#ss12}
--------------------------------

Age at revision arthroplasty of less than 60 years increased the risk of cup re-revision for any reason and due to aseptic loosening. That younger patients have an inferior outcome after primary THA is well known. In this group of patients, inferior survival of acetabular HA-coated cups has also been reported ([@CIT0014], [@CIT0022], [@CIT0033], [@CIT0011]). Higher demands in young patients and increased wear may explain the higher risk of revision. However, in the SHAR there is no distinction between loosening and osteolysis as causes of revision.

HA coating was a risk factor for isolated liner re-revisions, something that may be explained by "third-body wear" induced by HA particles. This phenomenon has been described as a cause of early failure of HA-coated cups after primary THA ([@CIT0015]).

Use of the Harris-Galante cup enhanced the risk of cup re-revision due to aseptic loosening and for any reason when compared with the Trilogy cup. The Trilogy cup has shown good long-term results after primary THA ([@CIT0011], [@CIT0026]). In revision cases, [@CIT0031] reported good medium-term results after using the Harris-Galante cup in acetabular revision, with only 1% component failure after an average follow-up time of 3.4 years. Long-term results (with 10--14 years of follow-up) for this cup used as a revision component have also been reported to be satisfactory ([@CIT0032], [@CIT0006]). The Trilogy cup is a new version of the Harris-Galante design where problems associated with the locking mechanism that secures the polyethylene liner have been addressed ([@CIT0025]).

Other factors affecting outcome after cup revision {#ss13}
--------------------------------------------------

The type of stem component and its fixation could influence cup survival and thereby possibly distort our findings. Different types of stems were combined with the cups investigated in our study; either they were left in situ at the time of the index revision surgery or they were exchanged during the same revision procedure ([Table 7](#T7){ref-type="table"}). The type of stem fixation varied, with the majority being cemented stems---giving hybrid revision THA. In order to investigate whether the type of stem fixation affected cup survival when both stem and cup were exchanged at the index revision, we performed a separate analysis including this variable (cemented or uncemented stem fixation) as a covariate. We found that stem fixation was not a statistically significant risk factor for cup re-revision for any reason ([Table 6](#T6){ref-type="table"}) or due to aseptic loosening.

###### 

Distribution of the 3 most commonly used stems combined with the cup types Trilogy (A) and Harris-Galante (B)

                             \+ HA   -- HA         
  -------------------------- ------- ------- ----- -----
  *A. Trilogy cup*                                 
    Lubinus SPII             238     20      23    9
    Exeter polished          118     10      25    10
    Wagner SL rev. lateral   32      3       36    15
    Others                   804     67      164   66
                             1,192   100     248   100
  *B. Harris-Galante cup*                          
    Lubinus SPII             13      17      31    12
    Charnley                 9       12      35    13
    Spectron EF              12      15      16    6
    Others                   44      56      180   69
                             78      100     262   100

It is conceivable that some stems were thought to be stable at the time of the index operation and left in situ while in truth they were unstable. Furthermore, stems left in situ could influence the results, causing difficulties in correct balancing of the soft tissues, and increase the risk of subsequent taper corrosion or dislocation---with a possible influence on the risk of further revisions. To avoid this potential bias, we investigated 2 groups separately according to the type of index revision procedure, e.g. only cup revisions or combined cup and stem revisions. We found no differences between these groups.

Due to the large number of degrees of freedom when entering each individual stem type into a Cox regression model, such analyses were impossible to perform. We therefore studied the various cup and stem combinations in detail and found that HA-coated cups were not commonly used in combination with stems of inferior performance ([Table 7](#T7){ref-type="table"}).

The use of an uncemented cup in primary THA was a risk factor for cup re-revision due to aseptic loosening. To our knowledge, this phenomenon has not been described previously. The reason for this finding is unknown. It might be that uncemented cups were more often surrounded by focal osteolyses and osteoporosis due to stress shielding ([@CIT0003]). Loosening of cemented cups is often associated with a generalized widening of the acetabulum bordered by a sclerotic rim, which can be partly used for fixation of an uncemented revision cup. Larger acetabular bone defects and inferior bone quality may thus be possible reasons for inferior fixation of revision cups inserted after removal of failed uncemented implants.

The reason underlying the index cup revision was included as a covariate in the Cox regression model. We found that cups that were revised due to aseptic loosening were not more likely to be re-revised due to aseptic loosening than cups that were originally revised for other reasons. In contrast, when analyzing the endpoint cup re-revision for any reason, cups that were originally revised due to dislocation were more likely to undergo re-revision. The fact that dislocation is a risk factor for re-revision for any reason is probably related to a higher risk of recurrent dislocation after revision surgery. Patients undergoing cup revision due to dislocation have been found to be at higher risk of re-dislocation, possibly because of soft tissue laxity or patient-related factors such as cognitive impairment or neuromuscular disorders, age greater than 80 years, and a propensity to fall ([@CIT0020]). It appears that conventional revision cups such as those investigated in our study do not sufficiently address the problem of recurrent dislocation. Constrained or dual-mobility acetabular components should perhaps be considered, at least in some of these cases.

Factors such as medication with steroids, non-steroidal anti-inflammatory drugs, or bisphosphonates that are known to influence bone metabolism are not registered in the SHAR and cannot be analyzed in our study. The same applies to other possible confounding factors such as medical conditions that could have a direct or indirect influence on implant survival, e.g. osteoporosis; neurological, mental, and endocrine disorders; or overweight.

Limitations of the study {#ss14}
------------------------

One limitation of our study was that only 2 cup types were investigated. However, these designs were the only ones available in the SHAR for studies of the effect of HA coating on cup survival after revision arthroplasty. On the other hand, the comparatively large number of revision operations in each group was a strength of our study. To our knowledge, no studies with comparable numbers of patients have been published.

A further limitation was the lack of detailed information on the extent of the acetabular defects and the amount and type of bone graft used during the index cup revision. Especially in Paprosky type III defects ([@CIT0019]), the use of large-diameter implants---sometimes in conjunction with bone grafting---is often advocated. Supplementary screws and morselized or structural bone grafts are commonly applied to restore the defects that are present during cup revision surgery. In cases of severe acetabular defects, the outcome after revision arthroplasty has resulted in inferior outcomes compared with revisions of Paprosky type I and II acetabular defects ([@CIT0008], [@CIT0021]). That is also confirmed by our subgroup analysis where re-revision of the metal shell due to aseptic loosening was the endpoint. We found that the use of bone graft at the index cup revision was a risk factor for re-revision of the metal shell, possibly reflecting larger acetabular defects and inferior initial (and even long-term) stability. Even if details about the bone defects and grafting are lacking, we have no reason to believe that these circumstances were unevenly distributed between the 2 groups of implants. Importantly, we found no differences between the 2 groups of revision cups with or without HA coating with respect to the use of bone grafts ([Table 3](#T3){ref-type="table"}). Altogether, we have no reason to believe that the size of the acetabular defects at revision surgery skewed our results.

Other information such as the use of additional screw fixation of the cups or the type of polyethylene liner (XLPE or conventional models) is not registered in the revision database, and was therefore not considered in our analyses.

Conclusion {#ss15}
----------

Our results, derived from registry data on 1,780 acetabular hip revisions, lend no support to the notion that HA coating improves the performance of revision cups. On the contrary, HA coating can increase the risk of liner revision, possibly due to third-body wear. Dislocation as the underlying diagnosis for the index revision and age below 60 years at the index cup revision are patient-related risk factors for subsequent cup re-revision. The type of stem fixation at index cup revision did not affect the risk of cup re-revision whereas other technical factors such as the use of a Harris-Galante cup at the index cup revision and uncemented cup fixation at primary THA increased the risk of subsequent re-revision of the cup. Bone grafting is a risk factor for re-revision of the metal shell due to aseptic loosening, probably reflecting a higher degree of acetabular bone deficiency at the time of index cup revision.
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